Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.45 CNY
205.01 M CNY
936.62 M CNY
295.49 M
About HUNAN HANSEN PHARM
Sector
CEO
Zheng Qing Liu
Headquarters
Yiyang
Website
Founded
1998
ISIN
CNE100000PK2
FIGI
BBG000Q7Z266
Hunan Hansen Pharmaceutical Co. Ltd. engages in the research, development, production, manufacture, and sales of traditional Chinese medicines. Its products include intravenous medicine, capsules, syrups, and pills for cardiovascular, respiratory, orthopedic diseases, cerebrovascular diseases, and gastrointestinal diseases. The company was founded on January 21, 1998 and is headquartered in Hunan, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 002412 is 6.35 CNY — it has decreased by −0.78% in the past 24 hours. Watch HUNAN HANSEN PHARM stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange HUNAN HANSEN PHARM stocks are traded under the ticker 002412.
002412 stock has risen by 2.92% compared to the previous week, the month change is a 9.11% rise, over the last year HUNAN HANSEN PHARM has showed a −7.97% decrease.
002412 reached its all-time high on Jun 15, 2015 with the price of 23.82 CNY, and its all-time low was 4.08 CNY and was reached on Feb 6, 2024. View more price dynamics on 002412 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
002412 stock is 1.90% volatile and has beta coefficient of 1.17. Track HUNAN HANSEN PHARM stock price on the chart and check out the list of the most volatile stocks — is HUNAN HANSEN PHARM there?
Today HUNAN HANSEN PHARM has the market capitalization of 3.24 B, it has increased by 4.73% over the last week.
Yes, you can track HUNAN HANSEN PHARM financials in yearly and quarterly reports right on TradingView.
HUNAN HANSEN PHARM is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
002412 net income for the last quarter is 30.26 M CNY, while the quarter before that showed 42.23 M CNY of net income which accounts for −28.35% change. Track more HUNAN HANSEN PHARM financial stats to get the full picture.
Yes, 002412 dividends are paid annually. The last dividend per share was 0.30 CNY. As of today, Dividend Yield (TTM)% is 4.66%. Tracking HUNAN HANSEN PHARM dividends might help you take more informed decisions.
HUNAN HANSEN PHARM dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 4.89% and 90.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 14, 2024, the company has 1.54 K employees. See our rating of the largest employees — is HUNAN HANSEN PHARM on this list?
Like other stocks, 002412 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUNAN HANSEN PHARM stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUNAN HANSEN PHARM technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUNAN HANSEN PHARM stock shows the buy signal. See more of HUNAN HANSEN PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.